Covid-19: Morocco Will Continue Using “AstraZeneca” Vaccine

The Ministry of Health has not recorded any serious cases related to this vaccine since its first use in late January.

The Ministry of Health has not recorded any serious cases related to this vaccine since its first use in late January.

Morocco will not suspend the use of “AstraZeneca” vaccine like many European countries did, as reported by government sources.

Dr. Said Afif, President of InfoVac Morocco and member of the Scientific and Technical Committee in charge of developing the national strategy for vaccination against “SARS-Cov-2”, said, “in view of the opinions of the European Medicines Agency and the WHO as well as Moroccan data, there is no need to worry”, noting that “over 10 million doses have been administered in England without significant problems. England continues using AstraZeneca, as does India which will administer it to 300 million people”.

Afif added that “large-scale vaccination in England has reduced new cases, deaths and resuscitations for the elderly; the effect is visible in the statistics”.

This comes against the background of suspending the use of the “AstraZeneca” vaccine in several European countries; including Norway, Denmark, Germany, France, Italy and Spain, following deaths due to vein thrombosis among people who received the “AstraZeneca” vaccine.

Meanwhile, European health authorities are conducting additional tests to ensure safety of the “AstraZeneca” vaccine, although there is still no evidence linking the vaccine to these recent deaths.

It is noteworthy that the vaccination campaign in Morocco has included more than 4 million people, more than 1.7 million of whom received the first and second shots of the vaccine.

Get real time updates directly on you device, subscribe now.

You might also like

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More